Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:45 AM
Ignite Modification Date:
2025-12-26 @ 11:45 AM
NCT ID:
NCT04706416
Eligibility Criteria:
Inclusion Criteria:
* ≥18 years old
* Treated with N-acetyl glucosamine (NAG) as first-line treatment
* Present with coronavirus disease 2019 (COVID-19) symptoms (including but not limited to fever, cough, shortness of breath, sore throat, nasal congestion, malaise, headache, muscle pain, loss of taste and/or smell, diarrhea, and vomiting)
* Clinically diagnosed with COVID-19 by reverse transcription polymerase chain reaction (RT-PCR)
* No intubation prior to hospitalization and enrollment in the current study.
Exclusion Criteria:
* \<18 years old upon admission
* Allergy to NAG
* Allergy to shellfish
* Currently taking warfarin
* Currently pregnant or lactating
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT04706416
Study Brief:
Protocol Section:
NCT04706416